Canine distemper virus (CDV) infection of ferrets as a model for testing Morbillivirus vaccine strategies: NYVAC- and ALVAC-based CDV recombinants protect against symptomatic infection

Journal of Virology

Volumn 71, Issue 2, 1997, Pages 1506-1513

  Stephensen, Charles B ^a,b   Welter, Janet ^b   Thaker, Subhashchandra R ^a,d   Taylor, Jill ^c   Tartaglia, James ^c   Paoletti, Enzo ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c Virogenetics Corporation   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANINE DISTEMPER MORBILLIVIRUS; CONJUNCTIVITIS; DISEASE CONTROL; ERYTHEMA; FERRET; FEVER; LEUKOPENIA; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RASH; SYMPTOMATOLOGY; VIRUS INFECTION; WEIGHT REDUCTION;

EID: 0031035678     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.2.1506-1513.1997     Document Type: Article

References (59)

1. Aaby, P. 1988. Malnutrition and overcrowding/intensive exposure in severe measles infection: review of community studies. Rev. Infect. Dis. 10:478-491.
2. Aaby, P., K. Knudsen, F. Simondon, B. Samb, H. Whittle, A. M. Seck, and J. Bennett. 1994. High-titre measles vaccines for boys. Lancet 344:1226-1227. (Letter.)
3. Adams, J. M., and D. T. Imagawa. 1957. Immunological relationship between measles and distemper viruses. Proc. Soc. Exp. Biol. Med. 96:340-244.
4. Appel, M., and D. S. Robson. 1973. A microneutralization test for canine distemper virus. Am. J. Vet. Res. 34:1459-1463.
5. Appel, M. J. G., and W. V. Harris. 1988, Antibody titers in domestic ferret jills and their kits to canine distemper virus vaccine. J. Am. Vet. Med. Assoc 193:332-333.
6. Appel, M. J. G., S. Pearce-Kelling, and B. A. Summers. 1992. Dog lymphocyte cultures facilitate the isolation and growth of virulent canine distemper virus. J. Vet. Diagn. Invest. 4:258-263.
7. Baker, J. A. 1970. Measles vaccine for protection of dogs against canine distemper. J. Am. Vet. Med. Assoc. 156:1743-1746.
8. Bankamp, B., U. G. Brinckmann, A. Reich, S. Niewiesk, V. ter Meulen, and U. G. Liebert. 1991. Measles virus nucleocapsid protein protects rats from encephalitis. J. Virol. 65:1695-1700.
9. Barrett, T., D. K. Clarke, S. A. Evans, and B. K. Rima. 1987. The nucleotide sequence of the gene encoding the F protein of canine distemper virus: a comparison of the deduced amino acid sequence with other paramyxoviruses. Virus Res. 8:373-386.
10. Barrett, T., G. J. Belsham, S. M. Subbarao, and S. A. Evans. 1989. Immunization with a vaccinia recombinant expressing the F protein protects rabbits from challenge with a lethal dose of rinderpest virus. Virology 170:11-18.
11. Beauverger, P., R. Buckland, and T. F. Wild. 1993. Measles virus antigens induce both type-specific and canine distemper virus cross-reactive cytotoxic T lymphocytes in mice: localization of a common Ld-restricted nucleoprotein epitope. J. Gen. Virol. 74:2357-2363.
12. Beauverger, P., R. Buckland, and F. Wild. 1994. Measles virus hemagglutinin induces an Ld-restricted CD8+ cytotoxic T lymphocyte response to two specific epitopes. Virology 200:281-283.
13. Boom, R., C. J. A. Sol, M. M. M. Salimans, C. I. Jansen, P. M. E. W. Dillen, and J. V. Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
14. Brinckmann, U. G., B. Bankamp, A. Reich, V. ter Meulen, and U. G. Liebert. 1991. Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis. J. Gen. Virol. 72:2491-2500.
15. Brown, A. L., and R. E. McCarthy. 1974. Relationship between measles and canine distemper viruses determined by delayed type hypersensitivity reactions in dogs. Nature 248:344-345.
16. Cadoz, M., A. Strady, B. Meignier, J. Taylor, J. Tartaglia, E. Paoletti, and S. Plotkin. 1992. Immunisation with canarypox virus expressing rabies glycoprotein. Lancet 339:1429-1432.
17. Carpenter, J. W., M. J. G. Appel, R. C. Erikson, and M. N. Novilla. 1976. Fatal vaccine-induced canine distemper virus infection in black-footed ferrets. J. Am. Vet. Med. Assoc. 169:961-964.
18. Chalmers, W. S. K., and W. Baxendale. 1994. A comparison of canine distemper vaccine and measles vaccine for the prevention of canine distemper in young puppies. Vet. Rec. 135:349-353.
19. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
20. Crook, E., J. R. Gorham, and S. H. McNutt. 1958. Experimental distemper in mink and ferrets. I. Pathogenesis. Am. J. Vet. Res. 19:955-957.
21. Curran, M. D., D. K. Clarke, and B. K. Rima. 1991. The nucleotide sequence of the gene encoding the attachment protein H of canine distemper virus. J. Gen. Virol. 72:443-447.
22. DeLay, P. D., S. S. Stone, D. T. Karzon, S. Katz, and J. Enders. 1965. Clinical and immune response of alien hosts to inoculation with measles, rinderpest, and canine distemper viruses. Am. J. Vet. Res. 26:1359-1373.
23. de Vries, P., R. S. VanBinnendijk, P. VanDerMarcel, et al. 1988. Measles virus fusion protein presented in an immune-stimulating complex (Iscom) induces haemolysis-inhibiting antibodies, virus-specific T cells and protection in mice. J. Gen. Virol. 69:549-559.
24. Dorig, R, E., A. Marcil, and C. D. Richardson. 1994. CD46, a primate-specific receptor for measles virus. Trends Microbiol. 2:312-317.
25. Drillien, R., D. Spehner, A. Kirn, P. Giraudon, R. Buckland, F. Wild, and J. P. Lecocq. 1988. Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagalutinin or the fusion protein. Proc. Natl. Acad. Sci. USA 85:1252-1256.
26. Dudley, J. M., A. Nixon, and A. M. Mumford. 1978. Distemper and measles vaccines-a comparative trial. J. Small Anim. Prac. 19:463-468.
27. Engelke, D. R., P. A. Honer, and F. S. Collins. 1988. Direct sequencing of enzymatically amplified human genomic DNA. Proc. Natl. Acad. Sci. USA 85:544-548.
28. Garenne, M., O. Leroy, J. P. Beau, and I. Sene. 1991. Child mortality after high-titre measles vaccines: prospective study in Senegal. Lancet 338:903-907.
29. Giraudon, P., R. Buckland, and T. F. Wild. 1992. The immune response tO measles virus in mice. T-helper response to the nucleoprotein and mapping of the T-helper epitopes. Virus Res. 22(1):41-54.
30. Hall, W., R. Lamb, and P. W. Choppin. 1980. The polypeptides of canine distemper virus: synthesis in infected cells and relatedness to the polypeptides of other morbilliviruses. Virology 100:433-149.
31. Horvat, B., P. Rivailler, G. Varior-Krishnan, A. Cardoso, D. Gerlier, and C. Rabourdin-Combe. 1996. Transgenic mice expressing human measles virus (MV) receptor CD46 provide cells exhibiting different permissivites to MV infection. J. Virol. 70:6673-6681.
32. Jones, L., L. Giavedoni, J. T. Saliki, C. Brown, C. Mebus, and T. Yilma. 1993. Protection of goats against peste des petits ruminants with a vaccinia virus double recombinant expressing the F and H genes of rinderpest virus. Vaccine 11:961-964.
33. Kauffman, C. A., A. G. Bergman, and R. P. O'Connor. 1982. Distemper virus infection in ferrets: an animal model of measles-induced immunosuppression. Clin. Exp. Immunol. 47:617-625.
34. Krakowka, S., and A. L. Wallace. 1979. Lymphocyte-associated immune responses to canine distemper and measles viruses in distemper-infected gnotobiotic dogs. Am. J. Vet. Res. 40:669-672.
35. Liu, C., and D. L. Coffin. 1957. Studies on canine distemper infection by means of fluorescein-labeled antibody. I. The pathogenesis, pathology, and diagnosis of the disease in experimentally infected ferrets. Virology 3:115-131.
36. McChesney, M. B., and M. B. A. Oldstone. 1987. Viruses perturb lymphocyte functions: selected principles characterizing virus-induced immunosuppression. Annu. Rev. Immunol. 5:279-304.
37. Naniche, D., G. Varior-Krishnan, F. Cervoni, T. F. Wild, B. Rossi, C. Rabourdin-Combe, and D. Gerlier. 1993. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67:6025-6032.
38. Norrby, E., and M. N. Oxman. 1990. Measles virus, p. 1013-1044. In B. N. Fields, D. M. Knipe, R. M. Chanock, M. S. Hirsch. J. L. Melnick, T. P. Monath, and B. Roizman (ed.), Fields virology, 2nd ed., vol. 1. Raven Press, New York.
39. Norrby, E., G. Utter, C. Orvell, and M. J. Appel. 1986. Protection against canine distemper virus in dogs after immunization with isolated fusion protein. J. Virol. 58:536-541.
40. Park, J. Y., C. J. Peters, P. E. Rollin, T. G. Ksiazek, B. Gray, K. B. Waites, and C. B. Stephensen. Development of an RT-PCR assay for diagnosis of lymphocytic choriomeningitis virus (LCMV) infection and to use in a prospective surveillance study. J. Med. Virol., in press.
41. Perkus, M. E., K. Limbach, and E. Paoletti. 1989. Cloning and expression of foreign genes in vaccinia virus, using a host range selection system. J. Virol. 63:3829-3836.
42. Prydie, R. 1968. Resistance against canine distemper induced by measles virus. Vet. Rec. 83:554-559.
43. Romero, C. H., T. Barrett, S. A. Evans, R. P. Kitching, P. D. Gershon, C. Bostock, and D. N. Black. 1993. Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease. Vaccine 11:737-742.
44. Rozenblatt, S., O. Eizenberg, R. Ben-Levy, V. Lavie, and W.J. Bellini. 1985. Sequence homology within the morbilliviruses. J. Virol. 53:684-690.
45. Sheshberadaran, H., E. Norrby, K. C. McCullough, W. C. Carpenter, and C. Orvell. 1986. The antigenic relationship between measles, canine distemper and rinderpest viruses studied with monoclonal antibodies. J. Gen. Virol. 67:1381-1392.
46. Stephenson, J. R., and V. ter Meulen. 1979. Antigenic relationships between measles and canine distemper viruses: comparison of immune response in animals and humans to individual virus-specific polypeptides. Proc. Natl. Acad. Sci. USA 76:6601-6605.
47. Strating, A. 1975. Measles vaccine in dogs: efficacy against aerosol challenge with virulent canine distemper virus. J. Am. Vet. Med. Assoc. 167:59-62.
48. Tartaglia, J., M. E. Perkus, J. Taylor, E. K. Norton, J. C. Audonnet, W. I. Cox, S. W. Davis, J. van der Hoeven, B. Meignier, M. Riviere, B. Languet, and E. Paoletti. 1992. NYVAC: a highly attenuated strain of vaccinia virus. Virology 188:217-232.
49. Tartaglia, J., J. Taylor, W. I. Cox, J. Audonnet, M. E. Perkus, E. Paoletti, A. Radaelli, C. Morghen, B. Meignier, M. Riviere, and K. J. Weinhold. 1993. Novel poxvirus strains as research tools and vaccine vectors, p. 361-378. In W. C. Koff, F. Wong-Staal, and R. C. Kennedy (ed.), AIDS research reviews, vol. 3. Marcel Dekker, Inc., New York.
50. Taylor, J., S. Pincus, J. Tartaglia, C. Richardson, G. Alkhatib, D. Briedis, M. Appel, E. Norton, and E. Paoletti. 1991. Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge. J. Virol. 65:4263-4274.
51. Taylor, J., R. Weinberg, J. Tartaglia, C. Richardson, G. Alkhatib, D. Briedis, M. Appel, E. Norton, and E. Paoletti. 1992. Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. Virology 187:321-328.
52. Taylor, J., B. Meignier, J. Tartaglia, B. Languet, J. VanderHoeven, G. Franchini, C. Trimarchi, and E. Paoletti. 1995. Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian species. Vaccine 13:539-549.
53. Thormar, H., P, D. Mehta, M. R. Barshatzky, and H. R. Brown. 1985. Measles virus encephalitis in ferrets as a model for subacute sclerosing panencephalitis. Lab. Anim. Sci. 35:229-232.
54. Varsanyi, T. M., B. Morein, A. Love, and E. Norrby. 1987. Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein. J. Virol. 61:3896-3901.
55. Visser, I. K., E. J. Vedder, M. W. van de Bildt, C. Orvell, T. Barrett, and A. D. Osterhaus. 1992. Canine distemper virus ISCOMs induce protection in harbour seals (Phoca vitulina) against phocid distemper but still allow subsequent infection with phocid distemper virus-1. Vaccine 10(7):435-438.
56. Wild, T. F., A. Bernard, D. Spehner, and R. Drillien. 1992. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice. J. Gen. Virol. 73:359-367.
57. Wild, T. F., A. Bernard, D. Spehner, D. Villeval, and R. Drillien. 1993. Vaccination of mice against canine distemper virus-induced encephalitis with vaccinia virus recombinants encoding measles or canine distemper virus antigens. Vaccine 11:438-444.
58. Wyde, P. R., M. W. Ambrose, T. G. Voss, H. L. Meyer, and B. E. Gilbert. 1992. Measles virus replication in lungs of hispid cotton rats after intranasal inoculation. Proc. Soc. Exp. Biol. Med. 201:80-87.
59. Yilma, T., D. Hsu, L. Jones, S. Owens, M. Grubman, C. Mebus, M. Yamanaka, and B. Dale. 1988. Protection of cattle against rinderpest with vaccinia virus recombinants expressing the HA or F gene. Science 242:1058-1061.